Skip to Content
Discovering the causes of cancer and the means of prevention

Research News and HighlightsRSS

Information for Journalists

To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:


Phone: 240-760-6600

Stay Connected

Get updates on our training programs, scientific openings, and latest research findings on Twitter.

Blue bird Twitter icon links to


The following are highlighted research findings and scientific papers by DCEG investigators.

  • January 16, 2019

    Drug Overdose Deaths a National Problem, not Limited to Poor, Rural Counties

    Researchers in the NCI Division of Cancer Epidemiology and Genetics and collaborators at the National Institutes of Health conducted a formal analysis of overall death rates and death rates from drug poisoning among 25-64-year-olds in the United States. They compared rates across race/ethnicity, socioeconomic status, rurality and geography to determine whether increases in these deaths are limited to poor, rural, white communities in regions with high unemployment.

  • January 10, 2019

    AI Approach Outperformed Human Experts in Identifying Cervical Precancer

    A research team led by investigators from NIH and Global Good has developed a computer algorithm that can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention.

  • January 09, 2019

    BRCA Exchange Aggregates Data on Thousands of BRCA1 and BRCA2 Variants

    BRCA Exchange is a global resource with data and expert classification on thousands of inherited variants in the BRCA1 and BRCA2 genes that will improve cancer prevention, screening, and intervention for high-risk patients.

  • January 04, 2019

    HPV Screening History Important for Management of New, Abnormal Results

    HPV screening history of multiple negative HPV and cytology cotests important for management of current results in cervical cancer screening programs. The data come from over a million women aged 30 and older in Kaiser Permanente Northern California.

  • December 31, 2018

    Study finds elevated risk of certain rare blood cancers after chemotherapy for most solid tumors

    Findings from a new study by researchers at the National Cancer Institute (NCI) show that patients treated with chemotherapy for most solid tumors experienced an increased risk of myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML).

  • December 06, 2018

    Association between Benzene Exposure and Leukemia Risk Refined

    In a follow-up to a long-term study of Chinese workers exposed to benzene, DCEG researchers observed increased risks for the combined grouping of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) with increasing cumulative exposure for certain windows and ages of exposure.